Pharmacovigilance

Pharmacovigilance is the science that supervises the safety of medicines where the main objective is to establish preventive measures in the rational use of medicines. We evaluate adverse reactions to medicine to determine its causality, frequency and severity.

An adverse reaction is any harmful and unintended response that appears after the use of a drug in humans.

Technovigilance

Technovigilance is a set of activities that is responsible for identifying, evaluating, and disclosing information related to incidents that medical devices present, this has the purpose of protecting the health of all patients. It is constituted as a fundamental pillar in the evaluation to guarantee the safety of the use of these medical devices. The purpose of Technovigilance is to guarantee that medical devices available on the market function in the manner indicated according to the manufacturer’s intended use.

You can report an adverse reaction or incident that you have experienced while taking a medication or using a medical device from LABORATORIOS AMERICANOS SA. We are committed to collecting notifications of adverse reactions and incidents and, if applicable, reporting said information to the Health Authorities.

Release N 001/2023 (Information for health professionals and patients)

• Diclofenaco 75 mg/3 mL Injection Solution should not be mixed and applied with other injectable solutions. In this way we avoid drug interactions and possible adverse events.
• Diclofenaco 75 mg/3 mL Injectable Solution should only be used in adult patients.
• Before use, carefully read the Insert found inside the product box.
• The administration of the drug Diclofenaco 75 mg/3 mL Injectable Solution should only be performed by a health professional trained in the administration of injectables.
• Talk to your doctor to report any Adverse Event and you can contact the following means of communication:
  Email: ftvigilancia@labot.com.pe, lpedemonte@labot.com.pe, ncaceres@labot.com.pe, ranchayhua@labot.com.pe.
  Cell phones (Call, text message, WhatsApp): 965 402 087, 965 402 080, 965 402 127.
  Central Labot: +51 1 626 – 8600. Annexes: 6120, 6122, 6128, 6130.
  Voicemail.

Release N 002/2023 (Information for health professionals and patients)

• Metamizole Sodium 1g/2mL Solution for Injection should not be mixed and applied concomitantly with other solutions for injection. In this way we avoid incompatibility and possible adverse events.

• The administration of the drug Metamizole Sodium 1g/2mL Solution for Injection should only be performed by a health professional trained in administration of injectables.

• Before use, carefully read the Insert inside the product box.

• Talk to your doctor to report any Adverse Event and you can contact the following means of communication:
  Email: ftvigilancia@labot.com.pe, lpedemonte@labot.com.pe, ncaceres@labot.com.pe, ranchayhua@labot.com.pe.
  Cell phones (Call, text message, WhatsApp): 965 402 087, 965 402 080, 965 402 127.
  Central Labot: +51 1 626 – 8600. Annexes: 6120, 6122, 6128, 6130.
  Voicemail.

Release N 003/2023 (Information for patients and/or general public)

LABOT reminds you,

• How to know if the pharmacies where you purchase your medicines are authorized?

You can verify by accessing the DIGEMID website: http://serviciosweb.digemid.minsa.gob.pe/Consultas/Establecimientos, where the establishment’s status should appear as “ACTIVE,” which means it is authorized; otherwise, refrain from purchasing pharmaceutical products. This way, you contribute to the rational use of medications, ensuring their quality, efficacy, and safety.

• If you have any inquiries about any product, you can contact us through the following communication channels:

1. Email: ftvigilancia@labot.com.pe, lpedemonte@labot.com.pe, ncaceres@labot.com.pe, ranchayhua@labot.com.pe.
2. Mobile phones (Call, text message, WhatsApp): +51 965 402 087, +51 965 402 080, +51 965 402 127.
3. Labot Central: +51 1 626 – 8600. Extensions: 6120, 6122, 6128, 6130.
4. Voicemail.

Labot Website (Contact Us): https://labot.com.pe/en/contact/

For any questions, contact us at: